sifap2

Stroke in young Fabry patients

Stroke in Young Fabry Patients (sifap2):
Characterization of the Stroke Rehabilitation

Estimated enrollment:	100
Study start date:	April 2007
Study completion date:	November 2013 (Final data collection date)
Study homepage:	www.sifap.eu

Project overview

The purpose of this study is to investigate the stroke rehabilitation of Fabry patients during different therapeutic standard approaches for stroke and for Fabry disease (if any).

In sifap2 the relapse rate of acute cerebrovascular events with clinical relevance in patients with different prophylactic therapeutic approaches will be determined. Patients with a proven Fabry disease will be included in sifap2 for a minimum follow-up of 36 months to determine whether the differences in treatment are significant for patient recovery and on what they depend on.

All patients with any etiology of stroke and a diagnosed Fabry disease submitted to the stroke unit of the participating centres which commit to work with the EUSI (European Stroke Initiative) recommendations for stroke management and diagnosis will be included into the study.

Study contact

Sabine Rösner (ScO)

Fon: +49 381 494 47 97
Fax: +49 381 494 47 48

This study is officially registered under NCT00413595 on clinicaltrials.gov providing additional study information.